109 related articles for article (PubMed ID: 27699014)
1. Analysis of the add-on effect of α-glucosidase inhibitor, acarbose in insulin therapy: A pilot study.
Li FF; Fu LY; Xu XH; Su XF; Wu JD; Ye L; Ma JH
Biomed Rep; 2016 Oct; 5(4):461-466. PubMed ID: 27699014
[TBL] [Abstract][Full Text] [Related]
2. Influence of Acarbose on Plasma Glucose Fluctuations in Insulin-Treated Patients with Type 2 Diabetes: A Pilot Study.
Li FF; Xu XH; Fu LY; Su XF; Wu JD; Lu CF; Ye L; Ma JH
Int J Endocrinol; 2015; 2015():903524. PubMed ID: 26640487
[TBL] [Abstract][Full Text] [Related]
3. Effect of rosiglitazone on inflammatory cytokines and oxidative stress after intensive insulin therapy in patients with newly diagnosed type 2 diabetes.
Li J; Shen X
Diabetol Metab Syndr; 2019; 11():35. PubMed ID: 31073335
[TBL] [Abstract][Full Text] [Related]
4. Increased circulating resistin is associated with insulin resistance, oxidative stress and platelet activation in type 2 diabetes mellitus.
Santilli F; Liani R; Di Fulvio P; Formoso G; Simeone P; Tripaldi R; Ueland T; Aukrust P; Davì G
Thromb Haemost; 2016 Nov; 116(6):1089-1099. PubMed ID: 27709225
[TBL] [Abstract][Full Text] [Related]
5. Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: role of interleukin-6 and disease duration.
Davì G; Chiarelli F; Santilli F; Pomilio M; Vigneri S; Falco A; Basili S; Ciabattoni G; Patrono C
Circulation; 2003 Jul; 107(25):3199-203. PubMed ID: 12810609
[TBL] [Abstract][Full Text] [Related]
6. A study of the correlation of insulin resistance and leptin with inflammatory factors and vascular endothelial injury in T2DM patients with CHD.
Zhang J; Jin J; Liu J; He Y; Zhang P; Ye W; Zhu W; Li M
Exp Ther Med; 2018 Jul; 16(1):265-269. PubMed ID: 29896248
[TBL] [Abstract][Full Text] [Related]
7. Association between circulating cytokine levels, diabetes and insulin resistance in a population-based sample (CoLaus study).
Marques-Vidal P; Bastardot F; von Känel R; Paccaud F; Preisig M; Waeber G; Vollenweider P
Clin Endocrinol (Oxf); 2013 Feb; 78(2):232-41. PubMed ID: 22409372
[TBL] [Abstract][Full Text] [Related]
8. [Effects of rosiglitazone on inflammatory reaction and insulin resistance in obese patients with newly diagnosed type 2 diabetes].
Zhu HL; Yu RM; Huang XZ; Huang W
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun; 28(6):1050-1. PubMed ID: 18583261
[TBL] [Abstract][Full Text] [Related]
9. P2X7 Receptor Expression in Peripheral Blood Monocytes Is Correlated With Plasma C-Reactive Protein and Cytokine Levels in Patients With Type 2 Diabetes Mellitus: a Preliminary Report.
Wu H; Nie Y; Xiong H; Liu S; Li G; Huang A; Guo L; Wang S; Xue Y; Wu B; Peng L; Song M; Li G; Liang S
Inflammation; 2015 Dec; 38(6):2076-81. PubMed ID: 26021292
[TBL] [Abstract][Full Text] [Related]
10. Acarbose actions on insulin resistance and inflammatory parameters during an oral fat load.
Derosa G; Maffioli P; Ferrari I; Fogari E; D'Angelo A; Palumbo I; Randazzo S; Bianchi L; Cicero AF
Eur J Pharmacol; 2011 Jan; 651(1-3):240-50. PubMed ID: 21118681
[TBL] [Abstract][Full Text] [Related]
11. Association between serum values of C-reactive protein and cytokine production in whole blood of patients with type 2 diabetes.
Castoldi G; Galimberti S; Riva C; Papagna R; Querci F; Casati M; Zerbini G; Caccianiga G; Ferrarese C; Baldoni M; Valsecchi MG; Stella A
Clin Sci (Lond); 2007 Jul; 113(2):103-8. PubMed ID: 17362204
[TBL] [Abstract][Full Text] [Related]
12. Metabolic abnormalities in the genetically obese and diabetic Otsuka Long-Evans Tokushima Fatty rat can be prevented and reversed by alpha-glucosidase inhibitor.
Yamamoto M; Jia DM; Fukumitsu KI; Imoto I; Kihara Y; Hirohata Y; Otsuki M
Metabolism; 1999 Mar; 48(3):347-54. PubMed ID: 10094112
[TBL] [Abstract][Full Text] [Related]
13. Acarbose Add-on Therapy in Patients with Type 2 Diabetes Mellitus with Metformin and Sitagliptin Failure: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study.
Yang HK; Lee SH; Shin J; Choi YH; Ahn YB; Lee BW; Rhee EJ; Min KW; Yoon KH
Diabetes Metab J; 2019 Jun; 43(3):287-301. PubMed ID: 30604599
[TBL] [Abstract][Full Text] [Related]
14. Association of type 2 diabetes with cyclooxygenase-mediated inflammation and oxidative stress in an elderly population.
Helmersson J; Vessby B; Larsson A; Basu S
Circulation; 2004 Apr; 109(14):1729-34. PubMed ID: 15037525
[TBL] [Abstract][Full Text] [Related]
15. Effects of acarbose and siglitine on blood glucose fluctuation and islet β-cell function in patients with type 2 diabetes mellitus.
Wang RR; Lv ZM; Dan YP; Chen KY; Zhang C
J Biol Regul Homeost Agents; 2019; 33(2):365-374. PubMed ID: 30972995
[TBL] [Abstract][Full Text] [Related]
16. The effects of acarbose on chemokine and cytokine production in human monocytic THP-1 cells.
Lin YC; Chen YC; Hsiao HP; Kuo CH; Chen BH; Chen YT; Wang SL; Tsai ML; Hung CH
Hormones (Athens); 2019 Jun; 18(2):179-187. PubMed ID: 30827017
[TBL] [Abstract][Full Text] [Related]
17. Long-term effect of alpha-glucosidase inhibitor on late dumping syndrome.
Hasegawa T; Yoneda M; Nakamura K; Ohnishi K; Harada H; Kyouda T; Yoshida Y; Makino I
J Gastroenterol Hepatol; 1998 Dec; 13(12):1201-6. PubMed ID: 9918426
[TBL] [Abstract][Full Text] [Related]
18. [Clinical experience with an alpha glucosidase inhibitor (acarbose) in the treatment of non-insulin-dependent diabetes. Multicenter study].
García de los Ríos M; Mujica V; Muñoz S; Durruty P; Larenas G; López MI; Kuzmanic A; Pérez J; Flaskamp R; Cumsille F
Rev Med Chil; 1997 Aug; 125(8):856-62. PubMed ID: 9580485
[TBL] [Abstract][Full Text] [Related]
19. Effects of acarbose treatment on markers of insulin sensitivity and systemic inflammation.
Rudovich NN; Weickert MO; Pivovarova O; Bernigau W; Pfeiffer AF
Diabetes Technol Ther; 2011 Jun; 13(6):615-23. PubMed ID: 21488802
[TBL] [Abstract][Full Text] [Related]
20. Oxidative DNA damage is associated with inflammatory response, insulin resistance and microvascular complications in type 2 diabetes.
Tatsch E; De Carvalho JA; Hausen BS; Bollick YS; Torbitz VD; Duarte T; Scolari R; Duarte MM; Londero SW; Vaucher RA; Premaor MO; Comim FV; Moresco RN
Mutat Res; 2015 Dec; 782():17-22. PubMed ID: 26520687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
